Cost-outcome description of clinical pharmacist interventions in a university teaching hospital
Open Access
- 17 April 2014
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 14 (1) , 177
Abstract
Pharmacist interventions are one of the pivotal parts of a clinical pharmacy service within a hospital. This study estimates the cost avoidance generated by pharmacist interventions due to the prevention of adverse drug events (ADE). The types of interventions identified are also analysed. Interventions recorded by a team of hospital pharmacists over a one year time period were included in the study. Interventions were assigned a rating score, determined by the probability that an ADE would have occurred in the absence of an intervention. These scores were then used to calculate cost avoidance. Net cost benefit and cost benefit ratio were the primary outcomes. Categories of interventions were also analysed. A total cost avoidance of €708,221 was generated. Input costs were calculated at €81,942. This resulted in a net cost benefit of €626,279 and a cost benefit ratio of 8.64: 1. The most common type of intervention was the identification of medication omissions, followed by dosage adjustments and requests to review therapies. This study provides further evidence that pharmacist interventions provide substantial cost avoidance to the healthcare payer. There is a serious issue of patient’s regular medication being omitted on transfer to an inpatient setting in Irish hospitals.Keywords
This publication has 39 references indexed in Scilit:
- Proton pump inhibitors: potential cost reductions by applying prescribing guidelinesBMC Health Services Research, 2012
- Clinical pharmacist’s contribution to medication reconciliation on admission to hospital in IrelandInternational Journal of Clinical Pharmacy, 2012
- An agenda for UK clinical pharmacology: PharmacoeconomicsBritish Journal of Clinical Pharmacology, 2012
- A qualitative study of physicians' and nurses' experiences of multidisciplinary collaboration with pharmacists participating at case conferencesInternational Journal of Pharmacy Practice, 2011
- On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention studyCritical Care, 2010
- From NCE to NICE: the role of pharmacoeconomicsBritish Journal of Clinical Pharmacology, 2010
- Systematic reviews of economic evaluations: utility or futility?Health Economics, 2010
- Potentially inappropriate prescribing in an Irish elderly population in primary careBritish Journal of Clinical Pharmacology, 2009
- The contribution of a pharmacy admissions service to patient careClinical Medicine, 2008
- Vancomycin administration: the impact of multidisciplinary interventionsJournal of Clinical Pathology, 2007